Chronic obstructive pulmonary disease - Multisistemic disease;Kronična opstruktivna plućna bolest - Multisistemska bolest

Medicina

Volumn 45, Issue 1, 2009, Pages 60-64

  Matanić, Dubravka ^a   Flego, Veljko ^a   Barković, Igor ^a   Zeba, Ivica ^a   Kupanovac, Željko ^a   Bulat Kardum, Ljiljana ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Chronic obstructive pulmonary disease; Inflammation; Systemic disease

Indexed keywords

EID: 67650227977     PISSN: 00257729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (54)

1. Celli B R. Update on the managment of COPD. Chest 2008;133:1451-62.
2. Rabe FK, Beghe B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006. Am J Resp Crit Care Med 2007;175:1222-32.
3. Augusti AGN, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Resp J 2003;21:347-60.
4. Gan WQ, Man SFP, Senthilselvan D, Sin D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systemic review and a meta-analysis. Thorax 2004;59:574-80.
5. Van Eeden SF, Sin DD. Chronic obstructive respiratory disease: a chronic systemic inflammationary disease. Respiration 2008;75:224-8.
6. Pinto-Plata VM, Livnat G, Girish M, Cabral H, Masdin P, Linacre P et al. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 2007;131:37-43.
7. Curtis JL, Freeman CM, Hogg JC. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 2007;4:512-21.
8. Agusti A, Thomas A. Neff Lecture. Chronic obstructive pulmonary disease. A systemic disease. Proc Am Thorac Soc 2006;3:478-81.
9. Gompetrz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Resp J 2001;17:1112-19.
10. MacNee WW. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:258-66.
11. Agusti A. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4:522-5.
12. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Resp J 2006;28:1245-57.
13. Agusti A, Soriano JB. COPD as systemic disease. COPD 2008;5:133-8.
14. Eisner MD, Blanc PD, Yelin EH, Sydney S, Katz PP, Ackerson L et al. COPD as systemic disease: impact on physical functional limitations. Am J Med 2008;121:789-96.
15. Couillard A, Prefaut C. From muscule disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Resp J 2005;26:703-19.
16. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest. 2002;(Suppl):127-30.
17. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger XM. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor -kB. FASEB J 2001;15:1169-80.
18. Macnee W. Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med 2007;28:479-513.
19. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006;61:10-16.
20. Decramer M, De Benedetto F, Del Ponte A, Marinari S. Systemic effects od COPD. Respir Med. 2005;(Suppl):3-10.
21. Begin P, Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am Rev Resp Dis 1991;143:905-12.
22. Norwood RJ. A review of etiologies of depression in COPD. Int J Chron Obstruct Pulm Dis 2007;2:485-91.
23. Reid MB, Li YP. Tumor necrosis factor-alfa and muscule vasting: a cellular perspective. Resp Res 2001;2:269-72.
24. Van Staa TP, Leufkens HG, Cooper C. The epiemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int 2002;13:777-87.
25. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidites in chronic obstructive pulmonary disease . Proc Am Thorac Soc 2008;5:549-55.
26. Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008;5:133-8.
27. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: kaiser permanente Medical Care Program. Chest 2005;128:2068-75.
28. LeJemtel TH, Padeletti M, JelicS. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 2007;16:171-80.
29. Falk JA, Kadiev S, Criner GJ, Sharf SM, Minai O, Diaz P. Cardiac disease in chronic pulmonary obstructive disease. Proceedings of the ATS 2008;5:543-8.
30. Maclay JD, McAllister DA, MacNee W. Cardiovascular risc in chronic obstructive pulmonary disease. Respirology 2007;12:634-41.
31. Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K et all. Determinansts of systemic vascular funtion in patients with stabile COPD. Am J Resp Crit Care Med 2008;178:1211-8.
32. Jopa P, Petrasova D, Stancak B, Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 2006;130:326-33.
33. Marquis K, Maltais F, Poirier P. Cardiovascular manifestations in patients with COPD. Rev Mal Respir 2008;25:663-73.
34. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Hospitalization and mortality in the Lung Heart Study. Am J Resp Crit Care Med. 2002;166:333-39.
35. Pai KJ, Pischon T, Jing M, Manson JE, Hankinson S, Joshipura K et all. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351:2599-61.
36. Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006;61:23-8.
37. Treatment of chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 2008;5:848-855.
38. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Resp J 2008,31:204-12.
39. Van Manen JG, Bindels PJ, Jezermans CJ, van der Zee JS, Bottema BJ, Schade E. Prevalence of comorbidity in patients with chronic airway obstruction and controls over age 40. J Clin Epidemiol 2001;54:287-93.
40. Kinnunen T, Saynajakangas O, Tuuponen T, Keistinen T. Impact of comorbidities on the duration of COPD patients' hospital episodes. Respir Med 2003;97:143-6.
41. Monreal M, Munoz-Torrero JF, Naraine VS, Jimenez D, Solers S, Rabunal R et all. Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure. Am J Med 2006;119:851-8.
42. Moua T, Wood K. COPD and PE: a clinical dilemma. Int J Chron Obstruc Pulm Dis 2008;3:227-8.
43. Sevenoaks MJ, Stockley RA. Chronic obstructive pulmonary disease, inflammation and comorbidity - a common inflammatory phenotype? Resp Res 2006;186: 70-7.
44. Kempainen RR, Savik K, Whelan TP, Dunitz JM, Herrington CS, Billings JL. High prevalence of proximal and disatl gastroesophageal reflux disease in advanced COPD. Chest 2007;131:1666-71.
45. Roussos A, Philippou N, Krietsepi V, Anastasakou E, Alepopoulou D, Koursarakos P et al. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonar disease. Resp. Med 2005;99:279-84.
46. Pifarre R, Falguera M, Vicente-de-Vera C, Nogues C. Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med 2007;101:2139-44.
47. Dubey S, Powell CA. Update in lung cancer. Am J Resp Crit Care Med 2008; 177:941-6.
48. Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005; 60:992-7.
49. MacNee W. Update in chronic obstructive pulmonary disease 2007. Am J Resp Crit Care Med 2008;177:820-9.
50. Grundy SM, Cleeman JI, Daniels SR, Eckel RH, Gordon DJ, Savage PJ et al. Diagnosis and managment of the metabolic syndrome: An Amerian Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
51. Marquis K, Maltais F, Duguay V, Bezeau AM, LeBlanc P, Jobin J et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J. Cardiopulm Rehabil 2005;25:226-32.
52. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Resp J. 2001;(Suppl):50-9.
53. Tiengo A, Fadini GP, Avogaro A. The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab 2008;34:447-54.
54. Litonjua AA, Lazarus R, Sparrow D, Demolles D, Weiss ST. Lung function in type 2 diabetes: The Normative Aging Study. Respir Med 2005;99:1583-90.